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Background
Chronic inflammatory bowel disease (IBD) and Lynch
syndrome (LS) are associated with an increased risk for
developing colorectal cancer (CRC). After 8-10 years of
pan-ulcerative colitis (DC), the risk of CRC is 2%,
increasing by 0.5-1.0% annually. LS has been associated
with a 60-80% lifetime risk of CRC. It is unclear
whether individuals diagnosed with both IBD and LS
would have a cumulative risk or earlier age of onset of
CRC based on their diagnoses.
Method
Patients with IBD and a germline mismatch repair gene
(MMR) mutation were identified through the Familial
Gastrointestinal Cancer Registry at Mount Sinai Hospital
in Toronto, Canada. Information on their IBD diagnosis,
colorectal screening/surgery, medication use, family
history and genetic test results were collected (Table 1).
Results
Five of 329 (1.5%) individuals with germline MMR
mutations reported having a history of IBD.
Conclusions
Concurrent IBD and LS did not appear to predispose to
early-onset CRC in our small case series.
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Table 1
Case # 1 2 3 4 5
Gender M F F M F
Ethnicity Caucasian Jewish Caucasian Caucasian Caucasian
MMR Mutation MLH1 MSH2 MSH2 MSH2 MSH6
Age of IBD dx 27 20 27 32 23
Site of IBD Ileum Pancolitis Pancolitis Proctitis Pancolitis
Colectomy, age 21 57 43 44 63
Cancer/dysplasia CRC dx 21 LGC* None TVA/HGD** dx 44 Endometrial dx 57
Smoking hx N Y N Y N
IBD medication 5-ASA N Y Y Y Y
Steroids N Y Y N Y
Antibiotics N Y Y Y N
Age of CRC in 1
0 or 2
0 kin # of kin 2 3 2 4 5
Mean age 40.5 30.7 35.5 49.7 78.4
*LGD – low-grade dysplasia on random screening biopsy
**TVA/HGD – tubulovillous adenoma with foci of high-grade dysplasia
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